MAP2K7 and status epilepticus: Administration of the activator of PGC-1α, resveratrol, was accompanied by increased VEGF and VEGFR2 expression, and promotion of PI3K/AKT and MEK/ERK pathways and decreased neuronal cell death in the hippocampus following status epilepticus.